|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.875 AUD | -0.86% |
|
-1.54% | -2.21% |
| 01-15 | Consumer Sector Helped by Spending Capacity, But Consumers Remain Cautious, Jarden Says | MT |
| 12-16 | Sigma Healthcare May Benefit From UK's Pharmacy Store Regulation, Says Jefferies | MT |
| Capitalization | 33.35B 22.28B 19.21B 17.88B 16.65B 31B 2,022B 206B 81.12B 964B 83.57B 81.85B 3,522B | P/E ratio 2026 * |
45.6x | P/E ratio 2027 * | 37.9x |
|---|---|---|---|---|---|
| Enterprise value | 33.95B 22.68B 19.55B 18.2B 16.95B 31.55B 2,058B 209B 82.56B 982B 85.06B 83.31B 3,585B | EV / Sales 2026 * |
3.19x | EV / Sales 2027 * | 2.9x |
| Free-Float |
84.72% | Yield 2026 * |
1.33% | Yield 2027 * | 1.62% |
Last Transcript: Sigma Healthcare Limited
| 1 day | -0.86% | ||
| 1 week | -1.54% | ||
| Current month | -2.21% | ||
| 1 month | -4.17% | ||
| 3 months | -3.20% | ||
| 6 months | +4.55% | ||
| Current year | -2.21% |
| 1 week | 2.84 |  | 2.94 |
| 1 month | 2.82 | | 3.03 |
| Current year | 2.82 | | 2.96 |
| 1 year | 2.64 | | 3.32 |
| 3 years | 2.64 | | 3.32 |
| 5 years | 2.64 | | 3.32 |
| 10 years | 2.64 | | 3.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikesh Ramsunder
CEO | Chief Executive Officer | 55 | 31/01/2022 |
Richard Murray
DFI | Director of Finance/CFO | - | 12/10/2025 |
Martin Hawkins
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Sammells
CHM | Chairman | - | 05/07/2022 |
Vikesh Ramsunder
BRD | Director/Board Member | 55 | 31/01/2022 |
Neville Mitchell
BRD | Director/Board Member | 67 | 01/02/2023 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.86% | -1.54% | - | - | 22.28B | |
| -0.43% | +2.99% | +41.83% | +122.11% | 104B | |
| -0.47% | +5.64% | +68.25% | +177.82% | 50.48B | |
| -0.54% | -2.40% | +17.46% | -20.26% | 9.71B | |
| -1.03% | -2.91% | -10.33% | -6.42% | 8.35B | |
| -0.19% | -0.19% | +3.21% | +7.08% | 8.25B | |
| +3.15% | +3.75% | +15.55% | +79.61% | 6.95B | |
| -0.51% | -0.15% | +25.30% | +32.93% | 6.1B | |
| -2.78% | -0.76% | +6.71% | +2.82% | 3.76B | |
| Average | -0.41% | +0.70% | +21.00% | +49.46% | 24.4B | |
| Weighted average by Cap. | -0.43% | +2.62% | +41.46% | +112.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.63B 7.1B 6.12B 5.7B 5.31B 9.88B 645B 65.57B 25.86B 307B 26.64B 26.09B 1,123B | 11.63B 7.77B 6.7B 6.24B 5.81B 10.81B 705B 71.73B 28.28B 336B 29.14B 28.54B 1,228B |
| Net income | 730M 487M 420M 391M 364M 678M 44.23B 4.5B 1.77B 21.1B 1.83B 1.79B 77.04B | 872M 583M 502M 468M 435M 811M 52.87B 5.38B 2.12B 25.22B 2.19B 2.14B 92.08B |
| Net Debt | 594M 397M 342M 319M 297M 553M 36.04B 3.67B 1.45B 17.19B 1.49B 1.46B 62.77B | 320M 214M 184M 171M 160M 297M 19.39B 1.97B 778M 9.25B 801M 785M 33.77B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/01/26 | 2.875 $ | -0.86% | 930,256 |
| 16/01/26 | 2.900 $ | +1.40% | 5,558,241 |
| 15/01/26 | 2.860 $ | +0.35% | 6,292,865 |
| 14/01/26 | 2.850 $ | -1.72% | 8,541,374 |
| 13/01/26 | 2.900 $ | -0.68% | 5,018,451 |
Delayed Quote Australian S.E., January 19, 2026 at 02:53 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- SIG Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition